Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease

被引:29
作者
Terp, BN
Cooper, DN
Christensen, IT
Jorgensen, FS
Bross, P
Gregersen, N
Krawczak, M
机构
[1] Univ Wales Coll Cardiff, Coll Med, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales
[2] Novo Nordisk AS, Med Chem Res, Malov, Denmark
[3] Royal Danish Sch Pharm, Dept Med Chem, Copenhagen, Denmark
[4] Aarhus Univ, Inst Expt Clin Res, Res Unit Mol Med, DK-8000 Aarhus, Denmark
关键词
missense mutation; biophysical properties; clinical detection; genotype-phenotype; molecular epidemiology; ARSA; AT3; SERPINC1; PAH; PROC; p53; TP53; TTR;
D O I
10.1002/humu.10095
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The inclusion of a mutation in a pathology based database such as the Human Gene Mutation Database (HGMD) is a two-stage process: first, the mutation must occur at the DNA level, then it must cause a clinically detectable disease state. The likelihood of the latter step, termed the relative clinical observation likelihood (RCOL), can be regarded as a function of the structural/functional consequences of a mutation at the protein level. Following this paradigm, we modeled in silico all amino acid replacements that could potentially have arisen from an inherited single base pair substitution in five human genes encoding arylsulphatase A (ARSA), antithrombin III (SERPINC1), protein C (PROC), phenylalanine hydroxylase (PAH), and transthyretin (TTR). These proteins were chosen on the basis of 1) the availability of a crystallographic structure, and 2) a sufficiently large number of amino acid replacements being logged in HGMD. A total of 9,795 possible mutant structures were modeled and 20 different biophysical parameters assessed. Together with the HGMD-derived spectra of clinically detected mutations, these data allowed maximum likelihood estimation of RCOL profiles for the 20 parameters studied. Nine parameters (including energy difference between wild-type and mutant structures, accessibility of the mutated residue, and distance from the binding/active site) exhibited statistically significant variability in their RCOL profiles, indicating that mutation-associated changes affected protein function. As yet, however, a biological meaning could only be attributed to the RCOL profiles of solvent accessibility and, for three proteins, local energy change, disturbed geometry, and distance from the active center. The limited ability of the biophysical properties of mutations to explain clinical consequences is probably due to our current lack of understanding as to which amino acid residues are critical for protein folding. However, since the proteins examined here were unrelated, and our findings consistent, it may nevertheless prove possible to extrapolate to other proteins whose dysfunction underlies inherited disease.
引用
收藏
页码:98 / 109
页数:12
相关论文
共 50 条
[1]   Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency [J].
Andresen, BS ;
Olpin, S ;
Poorthuis, BJHM ;
Scholte, HR ;
Vianey-Saban, C ;
Wanders, R ;
Ijlst, L ;
Morris, A ;
Pourfarzam, M ;
Bartlett, K ;
Baumgartner, ER ;
deKlerk, JBC ;
Schroeder, LD ;
Corydon, TJ ;
Lund, H ;
Winter, V ;
Bross, P ;
Bolund, L ;
Gregersen, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (02) :479-494
[2]  
[Anonymous], 1993, Human gene mutation
[3]  
Bayston TA, 1997, THROMB HAEMOSTASIS, V78, P339
[4]   Multiple test procedures other than Bonferroni's deserve wider use [J].
Bender, R ;
Lange, S .
BRITISH MEDICAL JOURNAL, 1999, 318 (7183) :600-601
[5]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[6]   The essence of SNPs [J].
Brookes, AJ .
GENE, 1999, 234 (02) :177-186
[7]  
Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO
[8]  
2-J
[9]   Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation [J].
Chasman, D ;
Adams, RM .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (02) :683-706
[10]   Long-read sequence analysis of the MECP2 gene in Rett syndrome patients:: correlation of disease severity with mutation type and location [J].
Cheadle, JP ;
Gill, H ;
Fleming, N ;
Maynard, J ;
Kerr, A ;
Leonard, H ;
Krawczak, M ;
Cooper, DN ;
Lynch, S ;
Thomas, N ;
Hughes, H ;
Hulten, M ;
Ravine, D ;
Sampson, JR ;
Clarke, A .
HUMAN MOLECULAR GENETICS, 2000, 9 (07) :1119-1129